EU: The Committee on Herbal Medicinal Products (HMPC) of the European Medicines Agency published a Q&A on cannabis-derived medicinal products and the scope of EU herbal monographs for herbal medicinal products within the EU medicines legislation on 15th February. The Q&A seeks to provide clarification on regulatory requirements to obtain a marketing authorisation for medicinal products, including cannabis-containing medicinal products, in the EU, as well » Continue Reading....
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.